Albert Galaburda
Albert Galaburda | |
---|---|
Nationality | American |
Known for | Research on dyslexia |
Scientific career | |
Fields | Neuroscience |
Institutions | Harvard Medical School |
Albert Galaburda is an American neuroscientist known for his pioneering research on the neurological basis of dyslexia. He is a professor of neurology at Harvard Medical School and has made significant contributions to the understanding of language processing in the brain.
Early Life and Education[edit | edit source]
Albert Galaburda was born in . He pursued his medical education and specialized in neurology, eventually joining the faculty at Harvard Medical School.
Research and Contributions[edit | edit source]
Galaburda's research has primarily focused on the neurological underpinnings of dyslexia, a learning disorder characterized by difficulties with accurate and/or fluent word recognition and by poor spelling abilities. His work has helped to elucidate the structural and functional differences in the brains of individuals with dyslexia compared to those without the condition.
One of his notable contributions is the identification of cortical anomalies in the brains of dyslexic individuals. These anomalies include ectopias and microgyria, which are malformations in the cerebral cortex that can disrupt normal neural connectivity and language processing.
Professional Career[edit | edit source]
Albert Galaburda has held various academic and research positions throughout his career. He is currently a professor of neurology at Harvard Medical School and has been involved in numerous research projects and clinical studies related to dyslexia and other neurological disorders.
Awards and Honors[edit | edit source]
Throughout his career, Galaburda has received several awards and honors for his contributions to the field of neuroscience. These accolades recognize his groundbreaking research and his impact on the understanding and treatment of dyslexia.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD